Procter & Gamble Health Ltd
₹5015
-47.50 (0.94%)
Wed, 28 Oct 2026, 07:47 pm
Health Technology
Pharmaceuticals: Major
24.5KProcter & Gamble Health Share Price Live Chart
1 Day
-47.50 (0.94%)
No Result Found
Summary
Market Cap (in Cr)
8389.66
Net Profit (in Cr)
326.91
P/B
15.18
Sector P/E
47.36
P/E
24.36
EV/EBITDA
16.43
Debt/Equity (Industry)
0.08
Interest Cover (Industry)
121.74
ROCE (Industry)
21.63
RONW (Industry)
17.09
ROE
61.59
ROCE
76.88
Debt/Equity
0.02
EPS (TTM)
200.73
Dividend Yield
4.06
Book Value
316.01
Interest Cover
818.93
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (4.1x coverage).
- Procter & Gamble Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Procter & Gamble Health is profitable, therefore cash runway is not a concern.
- Procter & Gamble Health is profitable, therefore cash runway is not a concern.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Procter & Gamble Health's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Procter & Gamble Health's dividend is below the markets top 25% of dividend payers in India (3.08%).
- High level of physical assets or inventory.
- The average tenure for the Procter & Gamble Health board of directors is less than 3 years, this suggests a new board.
Shareholding
| Shareholders | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Promoters | 51.82 | 51.82 | 51.82 | 51.82 | 51.82 |
| FII | 6.42 | 6.33 | 6.20 | 6.97 | 7.24 |
| DII | 12.63 | 12.44 | 13.68 | 13.84 | 13.91 |
| Public | 29.13 | 29.42 | 28.31 | 27.37 | 27.04 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 6741 | 6161 | 5862 | 5581 | 5282 | 5001 | 4421 |
| Fibonacci | 6161 | 5939.44 | 5802.56 | 5581 | 5359.44 | 5222.56 | 5001 |
| Camarilla | 5722.50 | 5669.33 | 5616.17 | 5581 | 5509.83 | 5456.67 | 5403.50 |
Pivots Level: Classic
R3
+1160
6741
R2
+580
6161
R1
+281
5862
S1
-299
5282
S2
-580
5001
S3
-1160
4421
Moving Average
Period
Value
10-EMA
5230.73
20-EMA
5267.27
30-EMA
5339.25
50-EMA
5480.13
100-EMA
5637.61
200-EMA
5675.85
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 26 May 2026 | agm | ||
| 26 May 2026 | dividend | ₹45.00 Dividend /Share | 27 Aug 2026 |
| 26 May 2026 | board-meetings | Accounts, Final Dividend | |
| 06 Feb 2026 | dividend | ₹110.00 Dividend /Share | 12 Feb 2026 |
| 06 Feb 2026 | board-meetings | Quarterly Results | |
| 12 Jan 2026 | dividend | Special Dividend - Rs. - 50 | 12 Feb 2026 |
| 05 Nov 2025 | board-meetings | Quarterly Results, Interim Dividend | |
| 06 Aug 2025 | agm | ||
| 22 Jul 2025 | dividend | Final Dividend - Rs. - 45 | 22 Aug 2025 |
| 29 May 2025 | dividend | ₹45.00 Dividend /Share | 22 Aug 2025 |
Peer Comparison
Procter & Gamble Health Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Laurus Labs Ltd
Divis Laboratories Ltd
Zydus Lifesciences Ltd
Procter & Gamble Health Ltd About
Procter & Gamble Health in the business of manufacturing and marketing of pharmaceuticals.
Industry
Pharmaceuticals - Multinational
Founded
1967
Headquarters
CEO
MADHAVAN SAMPATH
Employees
Contact
Website
http://www.pghealthindia.com
investorgrievance.im@pg.com
Phone
91-22-62109000
Location
Godrej One 8th Floor, Projshanagar Vikhroli (East), Mumbai, Maharashtra, 400079
Procter & Gamble Health Ltd Company History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 6405 | 4106.95 | 03 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 44711 | 4106.95 | 03 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 44711 | 4106.95 | 03 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 6405 | 4106.95 | 03 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 23964 | 4147.5 | 19 Sept 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 23964 | 4147.5 | 19 Sept 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 3433 | 4147.5 | 19 Sept 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 3433 | 4147.5 | 19 Sept 2022 |
| SMALLER CAP WORLD FUND INC | bulk | Sell | 114498 | 549 | 13 Jan 2014 |
| RELIANCE MUTUAL FUND A/C RELIANCE PHARMA FUND | bulk | Buy | 256500 | 549 | 13 Jan 2014 |
Frequently Asked Questions
1.What is the stock price of Procter & Gamble Health Ltd?
As of 29/10/2026 at 1:17 AM, Procter & Gamble Health Ltd shares are trading at ₹5015.
2.What is the market cap. of Procter & Gamble Health Ltd?
As of 29/10/2026, the market capitalization of Procter & Gamble Health Ltd is ₹8,354.05 crore.
3.When was Procter & Gamble Health Ltd founded?
Procter & Gamble Health Ltd was founded in 1967.
4.What are the P/E and P/B ratios of Procter & Gamble Health Ltd?
As of 29/10/2026, Procter & Gamble Health Ltd has a P/E ratio of 25.46 and a P/B ratio of 15.18.
5.How can I buy shares of Procter & Gamble Health Ltd?
You can buy shares of Procter & Gamble Health Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Procter & Gamble Health Ltd?
As of September,2026, promoters hold 51.82% in Procter & Gamble Health Ltd, while FIIs, DIIs and public shareholders hold 6.42%, 12.63% and 29.13%, respectively.
7.Does Procter & Gamble Health Ltd pay dividends?
Yes, Procter & Gamble Health Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹45.00 Dividend /Share per share.
8.What is the dividend yield of Procter & Gamble Health Ltd?
As of 29 October, 2026, the dividend yield of Procter & Gamble Health Ltd stands at 3.08%.
9.What are the latest financial results of Procter & Gamble Health Ltd?
For the financial year ended March 2025, Procter & Gamble Health Ltd reported revenue of ₹1,245.00 crore and a net profit of ₹313.00 crore.
10.What is the Stock symbol of Procter & Gamble Health Ltd?
PGHL is the stock symbol of Procter & Gamble Health Ltd.
11.Who is the CEO of Procter & Gamble Health Ltd?
The CEO of Procter & Gamble Health Ltd is MADHAVAN SAMPATH.
